As part of my algo collection I also scan derivatives trades, in order to find unusual patterns and early indicators. This is the list of single trades by size from 08.12.2020. Such lists can prove useful when searching for active instruments when looking to increase exposure or leverage. The three stocks highlighted in the headline are from the Swiss Small & Mid Cap space I focus most attention on.
Small & Mid Cap + Foreign Shares Warrant Trades CHF >25’000.-
Symbol | Underlying | Price | Volume | Turnover | Issuer |
WTSANV | Tesla Inc. | 0.67 | 150’000 | 100’500 | Bank Vontobel |
TSXNJB | Tesla Inc. | 0.37 | 200’000 | 74’000 | Bank Julius Bär |
WUSABV | Devisen USD/CHF | 0.71 | 100’000 | 71’000 | Bank Vontobel |
BABIJB | Alibaba Group Hldg. | 0.68 | 100’000 | 68’000 | Bank Julius Bär |
VIFKJB | Vifor Pharma AG | 0.45 | 150’000 | 67’500 | Bank Julius Bär |
ASCBJB | Ascom Hldg. AG | 0.616 | 100’000 | 61’600 | Bank Julius Bär |
BAPUJB | Baloise N | 0.39 | 150’000 | 58’500 | Bank Julius Bär |
BKWOJB | BKW AG | 0.76 | 75’000 | 57’000 | Bank Julius Bär |
TEMAQZ | Temenos AG | 0.25 | 225’000 | 56’250 | Zürcher Kantonalbank |
VOWJJB | Volkswagen AG (Vz) | 0.36 | 150’000 | 54’000 | Bank Julius Bär |
LOGGJB | Logitech International SA | 0.99 | 53’000 | 52’470 | Bank Julius Bär |
BAPUJB | Baloise N | 0.34 | 150’000 | 51’000 | Bank Julius Bär |
SANLJB | Sanofi S.A. | 0.1 | 500’000 | 50’000 | Bank Julius Bär |
SANLJB | Sanofi S.A. | 0.1 | 500’000 | 50’000 | Bank Julius Bär |
SANLJB | Sanofi S.A. | 0.1 | 500’000 | 50’000 | Bank Julius Bär |
SANLJB | Sanofi S.A. | 0.1 | 500’000 | 50’000 | Bank Julius Bär |
TSXBJB | Tesla Inc. | 0.41 | 120’000 | 49’200 | Bank Julius Bär |
VIFKJB | Vifor Pharma AG | 0.45 | 100’000 | 45’000 | Bank Julius Bär |
IDIAHZ | Idorsia AG | 0.11 | 400’000 | 44’000 | Zürcher Kantonalbank |
WTSE8V | Tesla Inc. | 0.145 | 300’000 | 43’500 | Bank Vontobel |
BABIJB | Alibaba Group Hldg. | 0.68 | 50’000 | 34’000 | Bank Julius Bär |
WAMCNV | AMS AG | 0.29 | 115’000 | 33’350 | Bank Vontobel |
BOZOJB | Bobst Group S.A. | 0.329 | 100’000 | 32’900 | Bank Julius Bär |
APLWJU | Apple Inc. | 0.94 | 35’000 | 32’900 | UBS |
BOZOJB | Bobst Group S.A. | 0.325 | 100’000 | 32’500 | Bank Julius Bär |
TSLVJB | Tesla Inc. | 1.61 | 20’000 | 32’200 | Bank Julius Bär |
WAMCNV | AMS AG | 0.32 | 100’000 | 32’000 | Bank Vontobel |
AMGSWU | AMS AG | 0.63 | 46’500 | 29’295 | UBS |
WAMCNV | AMS AG | 0.29 | 100’000 | 29’000 | Bank Vontobel |
BIDJJB | Baidu Inc. | 0.29 | 100’000 | 29’000 | Bank Julius Bär |
ROXNJB | Zur Rose Group AG | 0.56 | 50’000 | 28’000 | Bank Julius Bär |
ROXNJB | Zur Rose Group AG | 0.52 | 50’000 | 26’000 | Bank Julius Bär |
WAMBLV | AMS AG | 0.26 | 100’000 | 26’000 | Bank Vontobel |
VIFKJB | Vifor Pharma AG | 0.43 | 60’000 | 25’800 | Bank Julius Bär |
On the topic of Tesla, you should read GMO comments:
Tesla has risen some 800% since the fall of 2019 on the back of 17% growth in vehicles sold. It now has a greater market cap than the sum of all the other U.S. automakers, all the European automakers, and all the Korean automakers, with Honda, Mazda, and Nissan thrown in for good measure. That collection of companies sold approximately 100 times as many cars as Tesla did in 2019. But Tesla isn’t the craziest thing that happened this year, and that is true even if we restrict ourselves to looking only at electric vehicle companies named after Nikola Tesla. This spring a wouldbe Tesla called Nikola went public via a reverse merger with a SPAC9 at a valuation of $3 billion. In the 2020 EV frenzy, it rose 10-fold to a market cap of about $30 billion. This company is a rare bird in the stock market, a pre-revenue manufacturing company. In fact, Nikola is not only pre-revenue, having never sold any vehicles it has produced, it has also never produced a vehicle. Further, it has not even built the factory in which it aspires to build the trucks that it has yet to sell. This summer, a report came out detailing allegations that almost all of the claims of Nikola’s Elon Musk wannabe founder over the few years of its existence were lies. That founder, Trevor Milton, was forced to resign and the company has yet to meaningfully refute any of the claims made in the report. The stock duly fell, but even after information came out showing that pretty much everything the company has claimed to accomplish in its history was a lie, it still has a market cap more than three times its value at its public debut less than a year ago – a valuation that was presumably predicated on the company’s claims actually being true.
And on Nikola you should read Hindenburg Research reporting, which is partly being referenced by GMO.
Large Cap Warrant Trades CHF >30’000.-
Symbol | Underlying | Price | Volume | Turnover | Issuer |
SREVJB | Swiss RE AG | 0.48 | 500’000 | 240’000 | Bank Julius Bär |
WTNESU | Nestlé S.A. | 0.78 | 200’000 | 156’000 | UBS |
WTNESU | Nestlé S.A. | 0.78 | 200’000 | 156’000 | UBS |
WSIFVV | Sika AG | 1.35 | 100’000 | 135’000 | Bank Vontobel |
UTNMMU | Zurich Insurance Group AG | 0.86 | 100’000 | 86’000 | UBS |
UTNMMU | Zurich Insurance Group AG | 0.86 | 100’000 | 86’000 | UBS |
WYROGU | Roche AG | 0.84 | 100’000 | 84’000 | UBS |
WROBHV | Roche AG | 0.23 | 300’000 | 69’000 | Bank Vontobel |
SLHAMZ | Swiss Life Hldg. N | 0.68 | 100’000 | 68’000 | Zürcher Kantonalbank |
URROGU | Roche AG | 0.44 | 150’000 | 66’000 | UBS |
WSRAQV | Swiss RE AG | 0.39 | 140’000 | 54’600 | Bank Vontobel |
ROGUXU | Roche AG | 0.25 | 200’000 | 50’000 | UBS |
WNES9U | Nestlé S.A. | 0.48 | 100’000 | 48’000 | UBS |
SLHAFZ | Swiss Life Hldg. N | 0.32 | 150’000 | 48’000 | Zürcher Kantonalbank |
WZUBYV | Zurich Insurance Group AG | 0.95 | 50’000 | 47’500 | Bank Vontobel |
SLHAFZ | Swiss Life Hldg. N | 0.31 | 150’000 | 46’500 | Zürcher Kantonalbank |
SLHAFZ | Swiss Life Hldg. N | 0.31 | 150’000 | 46’500 | Zürcher Kantonalbank |
SLHAFZ | Swiss Life Hldg. N | 0.31 | 150’000 | 46’500 | Zürcher Kantonalbank |
WROBHV | Roche AG | 0.22 | 200’000 | 44’000 | Bank Vontobel |
WSRE6U | Swiss RE AG | 0.21 | 200’000 | 42’000 | UBS |
URROGU | Roche AG | 0.42 | 100’000 | 42’000 | UBS |
WROBHV | Roche AG | 0.21 | 200’000 | 42’000 | Bank Vontobel |
WTROGU | Roche AG | 0.82 | 50’000 | 41’000 | UBS |
WTROGU | Roche AG | 0.81 | 50’000 | 40’500 | UBS |
UTNMMU | Zurich Insurance Group AG | 0.87 | 46’000 | 40’020 | UBS |
URROGU | Roche AG | 0.4 | 100’000 | 40’000 | UBS |
WJNESU | Nestlé S.A. | 0.79 | 50’000 | 39’500 | UBS |
WJNESU | Nestlé S.A. | 0.77 | 50’000 | 38’500 | UBS |
SLHAFZ | Swiss Life Hldg. N | 0.25 | 150’000 | 37’500 | Zürcher Kantonalbank |
WLOANV | Lonza Group N | 0.145 | 250’000 | 36’250 | Bank Vontobel |
ROGWTU | Roche AG | 0.12 | 300’000 | 36’000 | UBS |
SLHAFZ | Swiss Life Hldg. N | 0.23 | 150’000 | 34’500 | Zürcher Kantonalbank |
ROGCBZ | Roche AG | 0.42 | 80’000 | 33’600 | Zürcher Kantonalbank |
ROGUMU | Roche AG | 0.55 | 60’000 | 33’000 | UBS |
WNOC3V | Novartis AG | 0.11 | 300’000 | 33’000 | Bank Vontobel |
LONAVZ | Lonza Group N | 1.62 | 18’800 | 30’456 | Zürcher Kantonalbank |
CSGWPU | Credit Suisse Group AG | 0.101 | 300’000 | 30’300 | UBS |
CSGWPU | Credit Suisse Group AG | 0.101 | 300’000 | 30’300 | UBS |
SLHUJB | Swiss Life Hldg. N | 0.43 | 70’000 | 30’100 | Bank Julius Bär |
ROWGZU | Roche AG | 0.1 | 300’000 | 30’000 | UBS |

Market Share and Turnover Total Value


Questions or feedback?
Feel free to write me at contact@zuberbuehler-associates.ch or add a comment.
Charts: source SIX Swiss Exchange.